Big Names in Biotech Seek $1M to Build Life-Size Statue of Legend Henri Termeer
The effort was announced last week by the Henri A. Termeer Tribute Committee. Source: BioSpace
The effort was announced last week by the Henri A. Termeer Tribute Committee. Source: BioSpace
Another experimental Alzheimer's disease treatment has failed in a late-stage study. Source: BioSpace
KaNDy Therapeutics is a clinical-stage company that is focused on female sex-hormone related conditions. Source: BioSpace
Immune-Onc Therapeutics launched in September 2016 and is headquartered in Palo Alto, California. Source: BioSpace
Lilly finally revealed the data in the New England Journal of Medicine. Source: BioSpace
After a brief stumble with UCART123 that resulted in a clinical hold last year, Cellectis is moving on with its study. Source: BioSpace
Spark won approval on Dec. 2017 as a one-time gene therapy to restore functional vision in children and adult patients with biallelic mutations of the RPE65. Source: BioSpace
Biotech and pharma execs Robert Mulroy and Dr. Debasish Roychowdhury announced today the launch of Partner Therapeutics, or PTx. Source: BioSpace
The company struck the cash-and-share deals to boost its presence in Europe. Source: BioSpace
The European Medicines Agency’s Committee for Medicinal Products for Human Use recommended marketing authorizations for 92 drugs and biologics in 2017, an increase from 81 in 2016 but down from…